Login
$ASPN
$5.08 +$0.00 (0.0%) After hours

$ASPN 8-K SEC Filings

Filed On Filing
05 Nov 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

Q3 2026 revenue of $85 million, up 71% quarter-over-quarter and above the high end of outlook

15 Sep 2026 8-K: Regulation FD Disclosure

September 15, 2026 ASPEN AEROGELS NYSE: ASPN INVESTOR PRESENTATION r D e c k | S e p t e m b e r 1 5 , 2 0 2 6

06 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Q2 2026 Thermal Barrier revenue of $29.5 million, up 81% quarter-over-quarter

18 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more

NORTHBOROUGH, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced the successful initiation of a staged restart of its manufacturing operations at its East Providence, Rhod...

07 May 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

East Providence manufacturing facility expected to have a staged restart beginning in May

21 Apr 2026 8-K: Regulation FD Disclosure; Other Events

NORTHBOROUGH, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today provided an update on its manufacturing facility in East Providence, Rhode Island.

25 Feb 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

$158.6 million year-end cash balance; $37.6 million GM commercial settlement payment expected in Q1 2026

18 Dec 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

This AMENDMENT NO. 2 TO CREDIT, SECURITY AND GUARANTY AGREEMENT (this “Agreement”), is made as of December 16, 2025 by and among ASPEN AEROGELS, INC., a Delaware corporation (“Parent”), ASPEN AEROGELS RHODE ISLAND, LLC, a Rhode Island li...

06 Nov 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Full-year 2025 outlook updated to reflect lower near-term EV production in North America

11 Sep 2025 8-K: Departure/Election of Directors or Officers; Compensation

This Executive Employment Agreement (this “Agreement”) is dated and shall be effective as of October 1, 2025 (the “Effective Date”), by and between Aspen Aerogels, Inc., a Delaware corporation (the “Company”), and Grant Thoele (the “Exec...

07 Aug 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

$78 million in quarterly revenue resulted in 32% gross margins and ~2X Adjusted EBITDA improvement QoQCFO transition to internal successor during Q3 ensures continuation of strategic direction and executionFixed cost structure reductions...

08 May 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Delivered revenues of $78.7 million and operating cash flow of $5.6 million

01 May 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

Establishment. Aspen Aerogels, Inc. (the “Company”) originally established the Aspen Aerogels 2023 Equity Incentive Plan, effective upon approval of the Plan by the stockholders of the Company at the 2023 Annual Meeting of Stockholders h...

07 Mar 2025 8-K: Departure/Election of Directors or Officers; Compensation

The three-year period beginning on January 1, 2025 and ending on December 31, 2027

06 Mar 2025 8-K: Departure/Election of Directors or Officers; Compensation

On March 4, 2025, Rebecca B. Blalock and Mark L. Noetzel notified the Board of Directors (the “Board”) of Aspen Aerogels, Inc. (the “Company”) of their intention to retire from the Board effective immediately after the Company’s 2025 Ann...

12 Feb 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

$452.7 million in FY 2024 revenue, a 90% year-over-year increase

19 Nov 2024 8-K: Amendments to or Waivers of the Code of Ethics

On November 14, 2024, the Board of Directors of Aspen Aerogels, Inc. (the “Company”) approved and adopted an amended and restated Code of Business Conduct and Ethics (the “Code”), to replace the Company’s existing Code in its entirety, a...

06 Nov 2024 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

$117.3 million in quarterly revenue, led by $90.6 million of Thermal Barrier revenue

22 Oct 2024 8-K: Entry into a Material Definitive Agreement; Other Events

As representatives (the “Representatives”) of the several Underwriters

16 Oct 2024 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

Aspen Aerogels, Inc. Receives Conditional Commitment for Proposed DOE Loan and Provides Q3 2024 Preliminary Financial Results

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support